Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei C Lau

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Pharmaceutical Research|October 25, 2006
Antiplatelet drug resistance and drug-drug interactions: Role of cytochrome P450 3A4Wei C Lau, Paul A Gurbel
Journal of the American College of Cardiology|September 5, 2006
Any need for preoperative cardiac testing in intermediate-risk patients with tight beta-adrenergic blockade?Kim A Eagle, Wei C Lau
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 1, 2009
The drug-drug interaction between proton pump inhibitors and clopidogrelWei C Lau, Paul A Gurbel
Circulation|May 4, 2005
Controversies in antiplatelet therapy for patients with cardiovascular diseaseEric R Bates, Wei C Lau
European Heart Journal|October 3, 2003
Drug-drug interactions involving antiplatelet agentsEric R Bates, Debabrata Mukherjee, Wei C Lau
Molecular Pharmacology|May 16, 2012
Formation of the thiol conjugates and active metabolite of clopidogrel by human liver microsomesHaoming Zhang, Wei C Lau, Paul F Hollenberg
Journal of the American College of Cardiology|January 22, 2008
Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrelPaul A Gurbel, Wei C Lau, Udaya S Tantry
Journal of the American College of Cardiology|March 12, 2011
Clopidogrel-drug interactionsEric R Bates, Wei C Lau, Dominick J Angiolillo
Circulation|May 25, 2005
Loading, pretreatment, and interindividual variability issues with clopidogrel dosingEric R Bates, Wei C Lau, Barry E Bleske
Circulation|August 11, 2004
Clinical significance of the atorvastatin-clopidogrel drug-drug interactionWei C Lau, David G M Carville, Eric R Bates
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Pharmaceutical Research|October 25, 2006
Antiplatelet drug resistance and drug-drug interactions: Role of cytochrome P450 3A4Wei C Lau, Paul A Gurbel
Journal of the American College of Cardiology|September 5, 2006
Any need for preoperative cardiac testing in intermediate-risk patients with tight beta-adrenergic blockade?Kim A Eagle, Wei C Lau
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 1, 2009
The drug-drug interaction between proton pump inhibitors and clopidogrelWei C Lau, Paul A Gurbel
Circulation|May 4, 2005
Controversies in antiplatelet therapy for patients with cardiovascular diseaseEric R Bates, Wei C Lau
European Heart Journal|October 3, 2003
Drug-drug interactions involving antiplatelet agentsEric R Bates, Debabrata Mukherjee, Wei C Lau
Molecular Pharmacology|May 16, 2012
Formation of the thiol conjugates and active metabolite of clopidogrel by human liver microsomesHaoming Zhang, Wei C Lau, Paul F Hollenberg
Journal of the American College of Cardiology|January 22, 2008
Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrelPaul A Gurbel, Wei C Lau, Udaya S Tantry
Journal of the American College of Cardiology|March 12, 2011
Clopidogrel-drug interactionsEric R Bates, Wei C Lau, Dominick J Angiolillo
Circulation|May 25, 2005
Loading, pretreatment, and interindividual variability issues with clopidogrel dosingEric R Bates, Wei C Lau, Barry E Bleske
Circulation|August 11, 2004
Clinical significance of the atorvastatin-clopidogrel drug-drug interactionWei C Lau, David G M Carville, Eric R Bates
Pageof 3